APA (7th ed.) Citation

Johnson, S. W., Finlay, L., Mathai, S. C., Goldstein, R. H., & Maron, B. A. (2022). Real‐world use of inhaled treprostinil for lung disease‐pulmonary hypertension: A protocol for patient evaluation and prescribing. Pulmonary Circulation, 12(3), 1. https://doi.org/10.1002/pul2.12126

Chicago Style (17th ed.) Citation

Johnson, Shelsey W., Lauren Finlay, Stephen C. Mathai, Ronald H. Goldstein, and Bradley A. Maron. "Real‐world Use of Inhaled Treprostinil for Lung Disease‐pulmonary Hypertension: A Protocol for Patient Evaluation and Prescribing." Pulmonary Circulation 12, no. 3 (2022): 1. https://doi.org/10.1002/pul2.12126.

MLA (9th ed.) Citation

Johnson, Shelsey W., et al. "Real‐world Use of Inhaled Treprostinil for Lung Disease‐pulmonary Hypertension: A Protocol for Patient Evaluation and Prescribing." Pulmonary Circulation, vol. 12, no. 3, 2022, p. 1, https://doi.org/10.1002/pul2.12126.